Kintor regeneration advances with new marketing partnership
The company says its new tie-up with Dekai Pharma involving its KX-826 hair-loss treatment could be worth 100 million yuan in sales Key Takeaways: Kintor shares rallied more than 8%…
Kintor Pharma shifts from cancer drugs to cosmetics as funds run low
The cash-strapped biotech has begun generating its first revenue from over-the-counter cosmetic treatments, as it pivots away from its original oncology drugs Key Takeaways: Kintor Pharma is shifting from its…
Kintor Pharma eyes regeneration with over-the-counter cosmetic treatments
The Suzhou-based drug developer said it will commercialize its hair-loss product despite disappointing clinical testing results, as it shifts away from cancer drugs Key Takeaways: Kintor announced it will commercialize…
